Linking DNA methylation in brain regions to Alzheimer’s disease risk: a Mendelian randomization study
Human Molecular Genetics · 2025
DOI: 10.1093/hmg/ddaf053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Hua Zhong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawai'i Cancer Center, University of Hawai'i at Mānoa, 701 Il…. Hauptthemen laut MEDLINE: DNA Methylation, Alzheimer Disease, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, University of Hawai'i Cancer Center, NIH.
Themen: Demenz
Abstract (Originalsprache)
Aim
DNA methylation in brain regions represents a potential mechanism linking genetic variation to Alzheimer’s disease (ad) risk, yet most studies have focused on blood-derived methylation markers. In this study, we conducted a systematic Mendelian randomization (MR) study to evaluate associations between predicted brain region-specific DNA methylation levels and ad risk, using methylation quantitative trait loci (mQTL) as genetic instruments.
Methods
We analyzed mQTLs from five human brain regions: cerebellum (CRBLM), frontal cortex (FCTX), causal pons (PONS), and temporal cortex (TCTX) from 600 individuals in Gibbs et al’s study, as well as mQTLs from dorsolateral prefrontal cortex (DLPFC) of 543 participants in the Religious Orders Study and the Rush Memory and Aging Project (ROSMAP). In our MR analyses, we integrated these mQTLs with single nucleotide polymorphisms (SNP)-ad risk summary statistics derived from 85 934 ad-related cases and 401 577 normal controls.
Results
Among 62 554 cytosine-guanine dinucleotide (CpG) sites, we identified 597 CpG sites (CpGs) significantly associated with ad risk (false discovery rate (FDR) < 0.05). Of these, 289 were confirmed through colocalization and summary-based MR (SMR) analyses, including one CpG site in CRBLM, 285 in DLPFC, one in FCTX, two in PONS, and one in TCTX. By integrating gene expression data, we identified 19 CpG sites with consistent associations across methylation levels, expression of eight target genes, and ad risk, including novel regulatory mechanisms involving RITA1’s modulation of cg11558705 and PCGF3’s regulation of cg10009224.
Conclusion
Our findings highlight brain region-specific DNA methylation as a mediator of genetic risk for ad, offering insights into ad pathogenesis and identifying potential therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawai'i Cancer Center, University of Hawai'i at Mānoa, 701 Ilalo St, Honolulu, HI 96813, United States.
- Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawai'i at Mānoa, 651 Ilalo Street, Honolulu, HI 96813, United States.
- School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine, 388 Yuhangtang Road, Hangzhou, Zhejiang 310058, China.
- Department of Biochemistry & Molecular Biology, University of Calgary, 2500 University Drive NW, Calgary Alberta T2N 1N4, Canada.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 7007 Bertner Avenue, Houston, TX 77030, United States.
- Department of Statistics and Data Science, University of Pennsylvania, 265 South 37th Street, Philadelphia, PA 19104, United States.
Förderung
- NCI NIH HHS
- University of Hawai'i Cancer Center
- NIH
Zitieren
APA
Zhong, H., Zhu, J., Liu, S., Zhou, D., Long, Q., Wu, C., Zhao, B., Cheng, C., Yang, Y., Wu, Q., Wu, Y., Li, C., Wang, Z., Wu, J., Guo, X., Zhi, D., Deng, Y., & Wu, L. (2025). Linking DNA methylation in brain regions to Alzheimer’s disease risk: a Mendelian randomization study. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf053
Vancouver
Zhong H, Zhu J, Liu S, Zhou D, Long Q, Wu C, et al. Linking DNA methylation in brain regions to Alzheimer’s disease risk: a Mendelian randomization study. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf053
BibTeX
@article{Zhong2025,
author = {Zhong, Hua and Zhu, Jingjing and Liu, Shuai and Zhou, Dan and Long, Quan and Wu, Chong and Zhao, Bingxin and Cheng, Chao and Yang, Yaohua and Wu, Qing and Wu, Yong and Li, Changwei and Wang, Zhaoming and Wu, Jianyong and Guo, Xingyi and Zhi, Degui and Deng, Youping and Wu, Lang},
title = {Linking DNA methylation in brain regions to Alzheimer’s disease risk: a Mendelian randomization study},
journal = {Human Molecular Genetics},
year = {2025},
doi = {10.1093/hmg/ddaf053}
}
EUVIMED